AIM movers: TEK4 joins AIM at a premium and Safestay buying and selling disappoints

Precision engineer TEK4 Group (LON: TEK4) joined AIM in the present day after elevating £2m at 200p/share. Existing shareholders raised £22.75m and the market capitalisation is £41m. The firm manufactures hole-drilling programs for aero engine and gasoline turbine elements. The money raised will assist to develop the present industry and transfer into medical gadgets. A brand new manufacturing unit will develop capability by 75%. The share worth is 38.8% larger at 277.5p.

Catenai (LON: CTAI) shares recovered 21.7% to 0.07p following information that investee firm Alludium has secured Sure Valley Ventures as a paying buyer of its agentic platform. On Friday the share worth slumped as a result of Innovate UK Loans had filed for the appointment of an administrator for investee firm Klarian. Catenai supplied a £450,000 unsecured convertible mortgage word facility to Klarian. When curiosity and costs are included, the quantity owed is greater than £762,000.

– Advertisement –

Atlantic Lithium (LON: ALL) says Elevra Lithium has accomplished the switch of the rights to Ewoyaa rights to Zhejiang Huayou Cobalt Co., Limited, which provides it a 22.5% curiosity in lithium initiatives in Ghana. The purchaser will sole fund improvement prices as much as $66m below stage 3 obligation. This can take its stake to 50%. That would go away Atlantic Lithium with 50% of the Ewoyaa lithium mission. The share worth improved 11.5% to fifteen.5p.

Helix Exploration (LON: HEX) has began drilling the Ross#1 properly on the Rudyard subject in Montana. This will take 21 days. There are three helium producing wells on the sphere with extra websites being assessed. The United States Department of Energy has designated helium as a important materials. The share worth elevated 10.1% to 30p.

FALLERS

Shares in Sareum (LON: SAR) returned from suspension down 38.2% to 17p after it raised £3.2m at 14p a share. A retail supply might increase an additional £100,000. The clinical-stage biotechnology firm is creating next-generation kinase inhibitors for autoimmune illness and most cancers. It will finance the SDC-1801 autoimmune illness inhibitor programme to a Phase 2-ready place and work on the neuroscience programme.

Hostels operator Safestay (LON: SSTY) says buying and selling stays beneath authentic expectations although there have been indicators of enchancment in current weeks. Asset disposals and financing options are being assessed. Costs are being diminished. Net debt was £16.2m on the finish of the primary half and subsequent disposals have diminished debt to £9.1m. Hostels in Lisbon and Brussels are being refurbished. This follows the departure of founder Larry Lipman. The share worth slipped 29.4% to 6p.

RiverGlobal (LON: RVRB) B shares fell 8.84% to 33p after administration introduced the intention to grasp the structured 30% fairness curiosity in Parmenion Capital Partners LLP after which wind up the corporate. The firm has acquired £1.1m in money for the ultimate fee for the share of RGH to Liontrust. A normal assembly shall be convened to realize shareholder approval for leaving AIM earlier than the top of the yr.

Monoclonal antibodies developer Bioventix (LON: BVXP) reported flat revenues of £13m, which was higher than anticipated. Pre-tax revenue was additionally flat at £10.3m. Cavendish expects little change in revenues and revenue this yr. Long-term progress will come from the tau/neuro antibody portfolio. The share worth declined 6.25% to £18.75.